Literature DB >> 22250070

Sf-6d population norms.

Bernard van den Berg1.   

Abstract

The derivation of population norms using simple generic health-related quality of life measures to inform policy has been recommended in the literature. This letter illustrates the derivation of population norms for the SF-6D in the United Kingdom. It uses a sample of 22,166 respondents from the 2010 wave of the study Understanding Society. Understanding Society is a national representative sample of British citizens. The survey of this study contains the SF-12. It is possible to derive health state utilities from the SF-12 (and from the SF-36) using a relatively new instrument, the SF-6D. The SF-12 and the SF-36 belong to the most widely used generic health-related quality of life measures. Mean SF-6D utility scores for males and females are 0.81 and 0.79, respectively. Especially the older age categories have lower utility scores. The younger age categories have slightly higher utility scores. From a list of 17 conditions, people with congestive heart failure had the lowest (0.60) and people with diabetes the highest (0.76) SF-6D scores. This letter encourages the health economics research community to derive SF-6D population norms to inform policy.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22250070     DOI: 10.1002/hec.1823

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  30 in total

1.  Preference-based health-related quality of life among victims of bullying.

Authors:  Linda Beckman; Mikael Svensson; Ann Frisén
Journal:  Qual Life Res       Date:  2015-08-14       Impact factor: 4.147

2.  Chilean population norms derived from the health-related quality of Life SF-6D.

Authors:  Miguel A Garcia-Gordillo; Daniel Collado-Mateo; Pedro R Olivares; José C Adsuar
Journal:  Eur J Health Econ       Date:  2017-06-19

3.  Evaluating a falls prevention intervention in older home care recipients: a comparison of SF-6D and EQ-5D.

Authors:  Maria Bjerk; Therese Brovold; Jennifer C Davis; Astrid Bergland
Journal:  Qual Life Res       Date:  2019-07-30       Impact factor: 4.147

4.  The relationship between SF-6D utility scores and lifestyle factors across three life stages: evidence from the Australian Longitudinal Study on Women's Health.

Authors:  Jeeva Kanesarajah; Michael Waller; Jennifer A Whitty; Gita D Mishra
Journal:  Qual Life Res       Date:  2017-02-03       Impact factor: 4.147

5.  SF-6D population norms for the Hong Kong Chinese general population.

Authors:  Carlos K H Wong; Brendan Mulhern; Garvin H L Cheng; Cindy L K Lam
Journal:  Qual Life Res       Date:  2018-05-24       Impact factor: 4.147

6.  Brazilian urban population norms derived from the health-related quality of life SF-6D.

Authors:  Rozana Mesquita Ciconelli; Marcos Bosi Ferraz; Sérgio Kowalski; Geraldo da Rocha Castelar Pinheiro; Emilia Inoue Sato
Journal:  Qual Life Res       Date:  2015-04-18       Impact factor: 4.147

7.  Normative values of EQ-5D-5L: in a Spanish representative population sample from Spanish Health Survey, 2011.

Authors:  M A Garcia-Gordillo; J C Adsuar; P R Olivares
Journal:  Qual Life Res       Date:  2015-10-19       Impact factor: 4.147

8.  SF-6D Portuguese population norms.

Authors:  Pedro L Ferreira; Lara N Ferreira; Luis N Pereira
Journal:  Eur J Health Econ       Date:  2014-02-07

9.  Association between knee symptoms, change in knee symptoms over 6-9 years, and SF-6D health state utility among middle-aged Australians.

Authors:  Ambrish Singh; Julie A Campbell; Alison Venn; Graeme Jones; Leigh Blizzard; Andrew J Palmer; Terence Dwyer; Flavia Cicuttini; Changhai Ding; Benny Antony
Journal:  Qual Life Res       Date:  2021-05-03       Impact factor: 4.147

10.  Cost-Effectiveness of Internet-Based Cognitive-Behavioral Treatment for Bulimia Nervosa: Results of a Randomized Controlled Trial.

Authors:  Hunna J Watson; Nicole McLagan; Stephanie C Zerwas; Ross D Crosby; Michele D Levine; Cristin D Runfola; Christine M Peat; Markus Moessner; Benjamin Zimmer; Sara M Hofmeier; Robert M Hamer; Marsha D Marcus; Cynthia M Bulik; Scott J Crow
Journal:  J Clin Psychiatry       Date:  2018 Jan/Feb       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.